Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors

Purpose: Few definitive treatment options exist for elderly patients diagnosed with early stage breast cancer who are medically inoperable or refuse surgery. Historical data suggest very poor local control with hormone therapy alone. We examined the dosimetric feasibility of hypofractionated radiati...

Full description

Bibliographic Details
Main Authors: Jonathan W. Lischalk, MD, Hao Chen, PhD, Michael C. Repka, MD, Lloyd D. Campbell, CMD, Olusola Obayomi-Davies, MD, Shaan Kataria, MD, Thomas P. Kole, MD, PhD, Sonali Rudra, MD, Brian T. Collins, MD
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109418300800

Internet

http://www.sciencedirect.com/science/article/pii/S2452109418300800

Similar Items